Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cybin | CBOE Canada | Healthcare | Biotechnology & Medical Research | $273.36M | -2.1x | -0.11 | $0.36 | 2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 177.8% Upside | Upgrade to Pro+ | |
Fennec Pharma | Toronto | Healthcare | Biotechnology & Medical Research | $212.59M | 54.8x | 0.51 | $7.77 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
NervGen Pharma | TSXV | Healthcare | Biotechnology & Medical Research | $200.01M | -5.9x | -1.27 | $2.82 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 56.8% Upside | Upgrade to Pro+ | |
Cardiol Therapeutics | Toronto | Healthcare | Biotechnology & Medical Research | $192.87M | -6.2x | -1.01 | $2.76 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 297.1% Upside | Upgrade to Pro+ | |
Medicenna | Toronto | Healthcare | Biotechnology & Medical Research | $163.36M | -5.7x | 0.04 | $2.11 | -4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 117.7% Upside | Upgrade to Pro+ | |
ZEN Graphene | TSXV | Healthcare | Biotechnology & Medical Research | $133.18M | -11.4x | -2.5 | $1.28 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Eupraxia Pharmaceuticals | Toronto | Healthcare | Biotechnology & Medical Research | $128.60M | -2.8x | -0.19 | $3.49 | -3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 358.3% Upside | Upgrade to Pro+ | |
Oncolytics Biotech | Toronto | Healthcare | Biotechnology & Medical Research | $100.08M | -3.4x | -0.27 | $1.30 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 457.7% Upside | Upgrade to Pro+ | |
Arch Biopartners | TSXV | Healthcare | Biotechnology & Medical Research | $90.96M | -43.5x | -2.7 | $1.48 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 136.5% Upside | Upgrade to Pro+ | |
Covalon Technologies | TSXV | Healthcare | Biotechnology & Medical Research | $76.24M | -90.3x | -0.42 | $3.07 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Zyus Life Sciences | TSXV | Healthcare | Biotechnology & Medical Research | $70.14M | -1.5x | -0.23 | $0.99 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 172.3% Upside | Upgrade to Pro+ | |
Satellos Bioscience | Toronto | Healthcare | Biotechnology & Medical Research | $57.55M | -2.5x | -0.11 | $0.51 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 140% Upside | Upgrade to Pro+ | |
Helix BioPharma Corp. | Toronto | Healthcare | Biotechnology & Medical Research | $56.37M | -7.8x | -12.35 | $1.15 | 4.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Microbix Biosystems Inc. | Toronto | Healthcare | Biotechnology & Medical Research | $49.12M | 9.7x | 0.03 | $0.36 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 116.2% Upside | Upgrade to Pro+ | |
MustGrow Biologics | TSXV | Healthcare | Biotechnology & Medical Research | $43.89M | -71.9x | -0.7 | $0.85 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
KDA Group | TSXV | Healthcare | Biotechnology & Medical Research | $43.87M | 3.9x | -0.01 | $0.22 | -6.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
NurExone Biologic | TSXV | Healthcare | Biotechnology & Medical Research | $43.87M | -4.3x | -0.18 | $0.65 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 509.8% Upside | Upgrade to Pro+ | |
Avicanna | Toronto | Healthcare | Biotechnology & Medical Research | $40.48M | -4.6x | -0.12 | $0.34 | -8.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Thiogenesis Therapeutics | TSXV | Healthcare | Biotechnology & Medical Research | $33.67M | -5.9x | 0.18 | $0.73 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Defence Therapeutics | CSE | Healthcare | Biotechnology & Medical Research | $29.14M | 0.04 | $0.62 | -3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Defence Therapeutics | CSE | Healthcare | Biotechnology & Medical Research | $29.14M | 0.04 | $0.62 | -3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
COSCIENS Biopharma | Toronto | Healthcare | Biotechnology & Medical Research | $25.96M | -0.4x | -0.04 | $8.33 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Resverlogix Corp. | Toronto | Healthcare | Biotechnology & Medical Research | $24.93M | -1.7x | 0.06 | $0.09 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Briacell Therapeutics | Toronto | Healthcare | Biotechnology & Medical Research | $19.93M | -2.1x | -0.03 | $1.11 | 12.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kane Biotech | TSXV | Healthcare | Biotechnology & Medical Research | $19.88M | -3.7x | 0.15 | $0.15 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BioMark Diagnostics Inc | CSE | Healthcare | Biotechnology & Medical Research | $17.15M | -12.9x | -0.47 | $0.23 | 4.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Telo Genomics | TSXV | Healthcare | Biotechnology & Medical Research | $16.03M | -5.1x | -2.43 | $0.22 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BetterLife Pharma Inc | CSE | Healthcare | Biotechnology & Medical Research | $14.24M | -0.6x | -0.07 | $0.11 | 10% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BetterLife Pharma Inc | CSE | Healthcare | Biotechnology & Medical Research | $14.24M | -0.6x | -0.07 | $0.11 | 10% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Numinus Wellness Inc | Toronto | Healthcare | Biotechnology & Medical Research | $11.22M | -0.4x | -0.01 | $0.04 | 16.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |